Malignant salivary gland tumours: can fast neutron therapy results point the way to carbon ion therapy?
Neutron therapy appears to be the treatment of choice for macroscopically incompletely excised and irresectable salivary gland tumours with improved survival rates. Further improvement may be achieved with other high LET modalities with a superior dose profile, such as carbon ions.
CD44v6 expression is associated with poor prognosis for Chinese HCC patients.